Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Further expands global clinical services business
September 11, 2018
By: Kristin Brooks
Managing Editor, Contract Pharma
PCI Pharma Services has entered an agreement to acquire Sherpa Clinical Packaging, a provider of clinical trial material management services for clinical studies, including packaging, labeling, distribution, storage and returns and destruction services. Sherpa’s facilities employ cold chain technologies that include handling products requiring labeling and kitting at frozen and refrigerated conditions. “Sherpa has always been committed to providing our customers with the best customer service and expertise in clinical supply management,” said Mark Paiz, president of Sherpa. “With this acquisition, our customers will now have access to PCI’s expanded clinical packaging services, extensive manufacturing of clinical trial materials, as well as global reach through U.S., European, and Asia Pacific depots to support their clinical studies.” PCI provides global molecule-to-market services that span contract development and manufacturing, including specialization in highly complex and potent drugs, clinical supply services and commercial packaging services. PCI’s clinical services include drug development and manufacturing, packaging and labeling, storage and logistical services, including support for Cold Chain and Ultra Cold Chain down to -196°C. The company is strategically investing in the expansion of its global Clinical Services business and this marks its third acquisition in 12 months. “We are extremely excited for what Sherpa brings to the PCI business,” said Salim Haffar, chief executive officer of PCI. “We have experienced considerable growth in our clinical business, and over the past 12 months made a number of key acquisitions to further expand our presence in key geographies including Ireland, Australia, and now California, along the way adding exciting new capabilities. Our #1 commitment to our clients is to provide the industry leading experience. This includes outstanding service, expansive capability, as well as the ability to support client studies around the world. Sherpa’s tremendous growth and reputation is clearly founded in their dedication to servicing their customers at the highest levels, which very much aligns to our core mission.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !